Oncopharmpod
Data Dive Into NK-1 Antagonists & Carboplatin
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:02
- Mas informaciones
Informações:
Sinopsis
ASCO's updated 2017 antiemetic guidelines recommend NK-1 antagonists to prevent CINV with standard Q 3 week carboplatin (i.e. AUC 5-6), but how good are the data to support that? We dive into the supporting data.
